RALEIGH, N.C.--(BUSINESS WIRE)-- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) on March 7, 2011 for ...
LAVAL, Quebec, May 27, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received ...
RALEIGH, N.C., Feb 23, 2010 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/comstock/15*!slxp/quotes/nls/slxp (SLXP 28.40, +4.15, +17.11%) today reported that ...
RALEIGH, N.C.-- (BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the topline results from the analysis of the microbiome, culture and susceptibility, and two key secondary ...
LAVAL, Quebec, May 6, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), ...
BRIDGEWATER, N.J., Oct. 1, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), ...
Bausch Health and its gastroenterology business, Salix Pharmaceuticals, announced that it has filed a patent infringement lawsuit in the U.S. District Court for the District of New Jersey against ...
* BAUSCH HEALTH - SALIX PARTIES AGREED TO RESOLVE OUTSTANDING IP LITIGATION WITH SANDOZ INC., REGARDING XIFAXAN (RIFAXIMIN) 550 MG TABLET * BAUSCH HEALTH - SALIX PARTIES WILL GRANT SANDOZ A ...
BRIDGEWATER, N.J., Oct. 1, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results